PART I Overview We are a biopharmaceutical company using our proprietary Precision Timed Release TM (PTR TM ) drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. With an initial focus on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, we a...
Q2 FY2026 — expected 2026-09-15
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-18 | 2025-12-31 | 0001493152-26-010882 | EDGAR | 113K words |
| 2025-03-27 | 2024-12-31 | 0001641172-25-000970 | EDGAR | — |
| 2024-04-01 | 2023-12-31 | 0001493152-24-012159 | EDGAR | — |
| 2023-03-10 | 2022-12-31 | 0001493152-23-007252 | EDGAR | — |
| 2022-03-28 | 2021-12-31 | 0001493152-22-007903 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-13 | 2025-09-30 | 0001493152-25-022395 | EDGAR | 26K words |
| 2025-08-19 | 2025-06-30 | 0001641172-25-024744 | EDGAR | — |
| 2025-05-08 | 2025-03-31 | 0001641172-25-009289 | EDGAR | — |
| 2024-11-07 | 2024-09-30 | 0001493152-24-043916 | EDGAR | — |
| 2024-08-13 | 2024-06-30 | 0001493152-24-031469 | EDGAR | — |
| 2024-05-08 | 2024-03-31 | 0001493152-24-018159 | EDGAR | — |
| 2023-11-13 | 2023-09-30 | 0001493152-23-040540 | EDGAR | — |
| 2023-08-14 | 2023-06-30 | 0001493152-23-028546 | EDGAR | — |
| 2023-05-10 | 2023-03-31 | 0001493152-23-016183 | EDGAR | — |
| 2022-11-14 | 2022-09-30 | 0001493152-22-031582 | EDGAR | — |
| 2022-08-11 | 2022-06-30 | 0001493152-22-021964 | EDGAR | — |
| 2022-05-12 | 2022-03-31 | 0001493152-22-013104 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-04-02 | 0001493152-26-014914 | EDGAR | 1K words |
| 2026-03-24 | 0001493152-26-012417 | EDGAR | — |
| 2026-03-18 | 0001493152-26-010881 | EDGAR | — |
| 2026-02-17 | 0001493152-26-006942 | EDGAR | — |
| 2026-02-06 | 0001493152-26-005561 | EDGAR | — |
| 2026-01-28 | 0001493152-26-004030 | EDGAR | — |
| 2026-01-15 | 0001493152-26-002417 | EDGAR | — |
| 2026-01-02 | 0001493152-26-000142 | EDGAR | — |
| 2025-12-15 | 0001493152-25-027667 | EDGAR | — |
| 2025-11-13 | 0001493152-25-022132 | EDGAR | — |
149 total filings indexed. 122 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001862150 |
| Ticker | CING |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.cingulate.com |
| Listed | 2021-12-08 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report